Preoperative Low Prealbumin Is Associated With Recurrence in Patients With Stage II/III Gastric Cancer After Laparoscopic D2 Gastrectomy

Overview

Journal Front Surg

Specialty General Surgery

Date 2022 Apr 18

PMID 35433809

Authors

Chun Gao

Ci Dian Dan Zeng

Yi Xin Tong

Li Zhu

Sheng Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Postoperative recurrence is associated with poor prognosis in patients with gastric cancer. This study aimed to explore predictive factors contributing to recurrence in patients with stage II/III gastric cancer after laparoscopic D2 gastrectomy.

Methods: This retrospective study was conducted at a single tertiary referral hospital. Patients diagnosed with gastric cancer who met the inclusion criteria were included in the study. The clinicopathological characteristics of the patients were collected. The patients were divided into recurrence and non-recurrence groups. The predictive factors were investigated using univariate and multivariate analyses.

Results: In total, 462 patients were included. The incidence of recurrence was 26.4% (122/462) in all patients. The most common recurrence pattern was haematogenous recurrence. In the multivariate analysis, the independent predictive factors for recurrence were serum prealbumin level ( < 0.001), prognostic nutritional index ( = 0.001), carbohydrate antigen 19-9 (CA19-9) ( < 0.001), number of lymph node metastases ( < 0.001), signet-ring cell carcinoma ( = 0.001), tumor deposit ( = 0.001), and no/incomplete adjuvant chemotherapy ( < 0.001).

Conclusions: Our findings revealed that nutritional status was an independent predictive factor for recurrence in patients with gastric cancer after D2 gastrectomy. We suggest that patients with risk factors for recurrence receive both nutritional support and intense surveillance.

Citing Articles

Preoperative low prealbumin independently predicts non-gastric cancer death after gastrectomy in elderly and young patients: a retrospective cohort study.

Matsui R, Nunobe S, Ri M, Makuuchi R, Irino T, Hayami M Surg Today. 2025; .

PMID: 39870988 DOI: 10.1007/s00595-025-02996-1.

The association between prealbumin concentration at admission and mortality in elderly patients with hip fractures: a cohort study.

Chen S, Zhang B, Zhang Y Arch Osteoporos. 2024; 19(1):27.

PMID: 38600249 DOI: 10.1007/s11657-024-01384-5.

Impact of preoperative prealbumin levels on long-term prognosis in patients with gastric cancer after gastrectomy: a retrospective cohort study.

Matsui R, Ida S, Ri M, Makuuchi R, Hayami M, Kumagai K Gastric Cancer. 2024; 27(3):611-621.

PMID: 38402291 DOI: 10.1007/s10120-024-01472-y.

Prealbumin as a nutrition status indicator may be associated with outcomes of geriatric hip fractures: a propensity score matching and 1-year follow-up study.

Liu M, Ji S, Yang C, Zhang T, Han N, Pan Y Aging Clin Exp Res. 2022; 34(12):3005-3015.

PMID: 36127624 DOI: 10.1007/s40520-022-02243-4.

References

Shen Q, Liu W, Quan H, Pan S, Li S, Zhou T . Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer. Br J Nutr. 2018; 120(12):1359-1369. DOI: 10.1017/S0007114518002854. View

Thommen D, Schumacher T . T Cell Dysfunction in Cancer. Cancer Cell. 2018; 33(4):547-562. PMC: 7116508. DOI: 10.1016/j.ccell.2018.03.012. View

Zhou J, Hiki N, Mine S, Kumagai K, Ida S, Jiang X . Role of Prealbumin as a Powerful and Simple Index for Predicting Postoperative Complications After Gastric Cancer Surgery. Ann Surg Oncol. 2016; 24(2):510-517. DOI: 10.1245/s10434-016-5548-x. View

Chang J, Kim K, Yoon H, Hyung W, Rha S, Kim H . Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer. Br J Surg. 2017; 104(7):877-884. DOI: 10.1002/bjs.10502. View

Yoo C, Noh S, Shin D, Choi S, Min J . Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000; 87(2):236-42. DOI: 10.1046/j.1365-2168.2000.01360.x. View

Unal D, Orhan O, Eroglu C, Kaplan B . Prealbumin is a more sensitive marker than albumin to assess the nutritional status in patients undergoing radiotherapy for head and neck cancer. Contemp Oncol (Pozn). 2014; 17(3):276-80. PMC: 3934060. DOI: 10.5114/wo.2013.35281. View

Eom B, Yoon H, Ryu K, Lee J, Cho S, Lee J . Predictors of timing and patterns of recurrence after curative resection for gastric cancer. Dig Surg. 2010; 27(6):481-6. DOI: 10.1159/000320691. View

Speiser D, Ho P, Verdeil G . Regulatory circuits of T cell function in cancer. Nat Rev Immunol. 2016; 16(10):599-611. DOI: 10.1038/nri.2016.80. View

Feng X, Chen Y, Wang W, Guan Y, Li Y, Chen S . Time-varying pattern of recurrence risk for gastric cancer patients. Med Oncol. 2013; 30(2):514. DOI: 10.1007/s12032-013-0514-y. View

10.

Veronese N, Fassan M, Wood L, Stubbs B, Solmi M, Capelli P . Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis. J Gastrointest Surg. 2016; 20(10):1692-8. DOI: 10.1007/s11605-016-3199-7. View

11.

Bollschweiler E, Boettcher K, Hoelscher A, Sasako M, Kinoshita T, Maruyama K . Is the prognosis for Japanese and German patients with gastric cancer really different?. Cancer. 1993; 71(10):2918-25. DOI: 10.1002/1097-0142(19930515)71:10<2918::aid-cncr2820711006>3.0.co;2-v. View

12.

. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011; 14(2):113-23. DOI: 10.1007/s10120-011-0042-4. View

13.

Jia R, Zhong J, Huo R, Su Q, Xiang X, Zhao F . Correlation between serum prealbumin and prognosis of patients with hepatocellular carcinoma after hepatectomy. J Surg Oncol. 2019; 119(6):794-800. DOI: 10.1002/jso.25378. View

14.

Markar S, Mikhail S, Malietzis G, Athanasiou T, Mariette C, Sasako M . Influence of Surgical Resection of Hepatic Metastases From Gastric Adenocarcinoma on Long-term Survival: Systematic Review and Pooled Analysis. Ann Surg. 2016; 263(6):1092-101. DOI: 10.1097/SLA.0000000000001542. View

15.

Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A . Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007; 357(18):1810-20. DOI: 10.1056/NEJMoa072252. View

16.

Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View

17.

Lai J, Kim S, Kim K, Li C, Oh S, Hyung W . Prediction of recurrence of early gastric cancer after curative resection. Ann Surg Oncol. 2009; 16(7):1896-902. DOI: 10.1245/s10434-009-0473-x. View

18.

Lee J, Chang K, Yoon C, Tang L, Strong V, Yoon S . Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma. Ann Surg. 2016; 267(1):105-113. PMC: 5515689. DOI: 10.1097/SLA.0000000000002040. View

19.

Lu J, Xu B, Zheng Z, Xie J, Wang J, Lin J . CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial. Gastric Cancer. 2018; 22(3):536-545. DOI: 10.1007/s10120-018-0892-0. View

20.

Luo H, Huang J, Zhu Z, Zhu P . Prognostic Value of Pretreatment Serum Transthyretin Level in Patients with Gastrointestinal Cancers. Dis Markers. 2019; 2019:7142065. PMC: 6589268. DOI: 10.1155/2019/7142065. View